Back
NewLake Capital Partners Vs. Immunovant Industry Stock Comparison
Sell
39
NLCP
NewLake Capital Partners
Last Price:
$14.86
Seasonality Move:
-4.5%
Sell
33
IMVT
Immunovant
Last Price:
$15.64
Seasonality Move:
21.61%
Sell
39
NewLake Capital Partners (NLCP)
is a Sell
Is NewLake Capital Partners a Buy, Sell or Hold?
-
The current NewLake Capital Partners [NLCP] share price is $14.86. The Score for NLCP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NLCP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Immunovant (IMVT)
is a Sell
Is Immunovant a Buy, Sell or Hold?
-
The current Immunovant [IMVT] share price is $15.66. The Score for IMVT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
IMVT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NLCP Stock Price Chart
What is NewLake Capital Partners's stock price today?
-
The NewLake Capital Partners share price today is $14.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLCP is experiencing selling pressure, which indicates risk of future bearish movement.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $15.66The current trend is relatively stagnant and IMVT is experiencing slight selling pressure.
NLCP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 58 | Buy |
Chaikin Money Flow: | -19890 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.3 - 14.84) | Buy |
Bollinger Bands (100): | (14.07 - 16.03) | Sell |
IMVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 52.17 | Buy |
Chaikin Money Flow: | -162153 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.15 - 15.91) | Buy |
Bollinger Bands (100): | (14.61 - 20.47) | Sell |
NLCP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.67 | Buy |
20-day SMA: | 14.58 | Buy |
50-day SMA: | 14.3 | Buy |
200-day SMA: | 17.05 | Sell |
8-day EMA: | 14.71 | Buy |
20-day EMA: | 14.6 | Buy |
50-day EMA: | 14.65 | Buy |
200-day EMA: | 16.19 | Sell |
IMVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.11 | Sell |
20-day SMA: | 15.27 | Buy |
50-day SMA: | 14.96 | Buy |
200-day SMA: | 22.97 | Sell |
8-day EMA: | 15.91 | Sell |
20-day EMA: | 15.51 | Buy |
50-day EMA: | 15.84 | Sell |
200-day EMA: | 21.13 | Sell |
NewLake Capital Partners Earnings Growth & NLCP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.
Immunovant Earnings Growth & IMVT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.07 per share, a decrease this year of $1.13 per share, and an increase next year of $0.02 per share.
NewLake Capital Partners Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Immunovant Technical Analysis
Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |